WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Quell has been featured in several forums during this year’s International Consumer Electronics Show (CES). Among the highlights:
- NeuroMetrix President and Chief Executive Officer, Shai N. Gozani, M.D., Ph.D., was interviewed in the Digital Health LIVE CES WebMD Lounge. The interview is available at: https://www.youtube.com/watch?v=QeyYQVXcZlY
- C|NET profiled Quell in their CES2015 center. The segment is available at: http://www.cnet.com/videos/quell-offers-wearable-pain-relief-without-medication/
- Quell was selected as one of four finalist in the Engadget Best of CES 2015 Digital Health and Fitness category. See http://www.engadget.com/2015/01/07/introducing-the-best-of-ces-2015-finalists/
Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. Users of the device will also have the option of using their smartphone to automatically track and personalize their pain therapy.
Consumers and medical professionals can visit QuellRelief.com to learn more and sign up to receive information. The company expects to begin taking pre-orders for Quell in March and to ship during the second quarter. Quell will initially be available exclusively through doctor’s office and online.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. For more information, please visit http://www.NeuroMetrix.com.
